To analyze UPF3A-specific effects, we generated a genetically modified MSI colon cancer cell line KM12-UPF3A (UPF3A−) that confers doxycycline (dox)-regulated wild type (WT) UPF3A expression in an isogenic background. Here, UPF3A is linked to malignant colon neoplasm.